Lung cancer with venous thrombo-embolism: clinical characteristics
Lung cancer is the most common malignancy diagnosed in patients with venous thrombo-embolism (VTE). To investigate clinical, biological, radiological features and survival of lung cancer patients with VTE. Retrospective case-control study investigating biologic, clinical course and survival of 25 pa...
Gespeichert in:
| Veröffentlicht in: | Tunisie Medicale 2011-07, Vol.89 (7), p.616-620 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 620 |
|---|---|
| container_issue | 7 |
| container_start_page | 616 |
| container_title | Tunisie Medicale |
| container_volume | 89 |
| creator | Racil, Hajer Laaribi, Ghaya Cherif, Hela Rouhou, Sana Cheikh Zidi, Asma Megdiche, Mohamed Lamine Chabbou, Abdellatif |
| description | Lung cancer is the most common malignancy diagnosed in patients with venous thrombo-embolism (VTE).
To investigate clinical, biological, radiological features and survival of lung cancer patients with VTE.
Retrospective case-control study investigating biologic, clinical course and survival of 25 patients lung cancers with VTE (Group M) and 50 lung cancers without VTE (group T).
The frequency of the VTE was 5.88% with 2.58% pulmonary embolism (PE). The mean age was 58 years ± 9.8 in group M and 57.9 years ± 9.6 in group T. No significant difference concerning medical or surgical history for both groups was found. The dyspnea and chest pain were at equal frequency (63.6%). Regarding the clinical probability of the PE, it was no significant differences between the two groups. A rate of D-dimer > 0.7μg/l was more frequent among group M (75% vs 20%; p = 0.054). The most common histological type was nonsmall cell lung cancer (88%). A stage IV was significantly more frequent in group M (86.4% vs. 52.3%; p = 0.007). The mean period of survival in Group M was 10.6 ± 1.2 month and 20.2 + 1.8 month in group T; p = 0.38.
The VTE associated to lung cancer is under diagnosed. Prospective studies are needed to establish more adapted scores. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_878823072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>878823072</sourcerecordid><originalsourceid>FETCH-LOGICAL-p556-65b31af76c0a48e12edba9c61868770d9fd353a06c98fed65b9fc66a2104736c3</originalsourceid><addsrcrecordid>eNo1j8tOwzAURL0AtVXpLyDvWEWy48R22EHFS4rEpvvo5uamMXIe2AmIvycSZRYzm6PRzBXbCZHJJJNKbtkhxg-xSgtZ5HLDtqk0Vgild-yxXIYzRxiQAv92c8e_aBiXyOcujH09JrSad7G_5-jd4BA8xw4C4EzBxdlhvGHXLfhIh0vu2en56XR8Tcr3l7fjQ5lMea4TnddKQms0CsgsyZSaGgrU0mprjGiKtlG5AqGxsC01K160qDWkUmRGaVR7dvdXO4Xxc6E4V72LSN7DQOvgyhprUyVMupK3F3Kpe2qqKbgewk_1_1r9Ajx9UyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878823072</pqid></control><display><type>article</type><title>Lung cancer with venous thrombo-embolism: clinical characteristics</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Racil, Hajer ; Laaribi, Ghaya ; Cherif, Hela ; Rouhou, Sana Cheikh ; Zidi, Asma ; Megdiche, Mohamed Lamine ; Chabbou, Abdellatif</creator><creatorcontrib>Racil, Hajer ; Laaribi, Ghaya ; Cherif, Hela ; Rouhou, Sana Cheikh ; Zidi, Asma ; Megdiche, Mohamed Lamine ; Chabbou, Abdellatif</creatorcontrib><description>Lung cancer is the most common malignancy diagnosed in patients with venous thrombo-embolism (VTE).
To investigate clinical, biological, radiological features and survival of lung cancer patients with VTE.
Retrospective case-control study investigating biologic, clinical course and survival of 25 patients lung cancers with VTE (Group M) and 50 lung cancers without VTE (group T).
The frequency of the VTE was 5.88% with 2.58% pulmonary embolism (PE). The mean age was 58 years ± 9.8 in group M and 57.9 years ± 9.6 in group T. No significant difference concerning medical or surgical history for both groups was found. The dyspnea and chest pain were at equal frequency (63.6%). Regarding the clinical probability of the PE, it was no significant differences between the two groups. A rate of D-dimer > 0.7μg/l was more frequent among group M (75% vs 20%; p = 0.054). The most common histological type was nonsmall cell lung cancer (88%). A stage IV was significantly more frequent in group M (86.4% vs. 52.3%; p = 0.007). The mean period of survival in Group M was 10.6 ± 1.2 month and 20.2 + 1.8 month in group T; p = 0.38.
The VTE associated to lung cancer is under diagnosed. Prospective studies are needed to establish more adapted scores.</description><identifier>ISSN: 0041-4131</identifier><identifier>PMID: 21780036</identifier><language>fre</language><publisher>Tunisia</publisher><subject>Case-Control Studies ; Humans ; Lung Neoplasms - complications ; Male ; Middle Aged ; Retrospective Studies ; Venous Thromboembolism - diagnosis ; Venous Thromboembolism - etiology</subject><ispartof>Tunisie Medicale, 2011-07, Vol.89 (7), p.616-620</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21780036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Racil, Hajer</creatorcontrib><creatorcontrib>Laaribi, Ghaya</creatorcontrib><creatorcontrib>Cherif, Hela</creatorcontrib><creatorcontrib>Rouhou, Sana Cheikh</creatorcontrib><creatorcontrib>Zidi, Asma</creatorcontrib><creatorcontrib>Megdiche, Mohamed Lamine</creatorcontrib><creatorcontrib>Chabbou, Abdellatif</creatorcontrib><title>Lung cancer with venous thrombo-embolism: clinical characteristics</title><title>Tunisie Medicale</title><addtitle>Tunis Med</addtitle><description>Lung cancer is the most common malignancy diagnosed in patients with venous thrombo-embolism (VTE).
To investigate clinical, biological, radiological features and survival of lung cancer patients with VTE.
Retrospective case-control study investigating biologic, clinical course and survival of 25 patients lung cancers with VTE (Group M) and 50 lung cancers without VTE (group T).
The frequency of the VTE was 5.88% with 2.58% pulmonary embolism (PE). The mean age was 58 years ± 9.8 in group M and 57.9 years ± 9.6 in group T. No significant difference concerning medical or surgical history for both groups was found. The dyspnea and chest pain were at equal frequency (63.6%). Regarding the clinical probability of the PE, it was no significant differences between the two groups. A rate of D-dimer > 0.7μg/l was more frequent among group M (75% vs 20%; p = 0.054). The most common histological type was nonsmall cell lung cancer (88%). A stage IV was significantly more frequent in group M (86.4% vs. 52.3%; p = 0.007). The mean period of survival in Group M was 10.6 ± 1.2 month and 20.2 + 1.8 month in group T; p = 0.38.
The VTE associated to lung cancer is under diagnosed. Prospective studies are needed to establish more adapted scores.</description><subject>Case-Control Studies</subject><subject>Humans</subject><subject>Lung Neoplasms - complications</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Venous Thromboembolism - diagnosis</subject><subject>Venous Thromboembolism - etiology</subject><issn>0041-4131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tOwzAURL0AtVXpLyDvWEWy48R22EHFS4rEpvvo5uamMXIe2AmIvycSZRYzm6PRzBXbCZHJJJNKbtkhxg-xSgtZ5HLDtqk0Vgild-yxXIYzRxiQAv92c8e_aBiXyOcujH09JrSad7G_5-jd4BA8xw4C4EzBxdlhvGHXLfhIh0vu2en56XR8Tcr3l7fjQ5lMea4TnddKQms0CsgsyZSaGgrU0mprjGiKtlG5AqGxsC01K160qDWkUmRGaVR7dvdXO4Xxc6E4V72LSN7DQOvgyhprUyVMupK3F3Kpe2qqKbgewk_1_1r9Ajx9UyA</recordid><startdate>201107</startdate><enddate>201107</enddate><creator>Racil, Hajer</creator><creator>Laaribi, Ghaya</creator><creator>Cherif, Hela</creator><creator>Rouhou, Sana Cheikh</creator><creator>Zidi, Asma</creator><creator>Megdiche, Mohamed Lamine</creator><creator>Chabbou, Abdellatif</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201107</creationdate><title>Lung cancer with venous thrombo-embolism: clinical characteristics</title><author>Racil, Hajer ; Laaribi, Ghaya ; Cherif, Hela ; Rouhou, Sana Cheikh ; Zidi, Asma ; Megdiche, Mohamed Lamine ; Chabbou, Abdellatif</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p556-65b31af76c0a48e12edba9c61868770d9fd353a06c98fed65b9fc66a2104736c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2011</creationdate><topic>Case-Control Studies</topic><topic>Humans</topic><topic>Lung Neoplasms - complications</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Venous Thromboembolism - diagnosis</topic><topic>Venous Thromboembolism - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Racil, Hajer</creatorcontrib><creatorcontrib>Laaribi, Ghaya</creatorcontrib><creatorcontrib>Cherif, Hela</creatorcontrib><creatorcontrib>Rouhou, Sana Cheikh</creatorcontrib><creatorcontrib>Zidi, Asma</creatorcontrib><creatorcontrib>Megdiche, Mohamed Lamine</creatorcontrib><creatorcontrib>Chabbou, Abdellatif</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tunisie Medicale</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Racil, Hajer</au><au>Laaribi, Ghaya</au><au>Cherif, Hela</au><au>Rouhou, Sana Cheikh</au><au>Zidi, Asma</au><au>Megdiche, Mohamed Lamine</au><au>Chabbou, Abdellatif</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lung cancer with venous thrombo-embolism: clinical characteristics</atitle><jtitle>Tunisie Medicale</jtitle><addtitle>Tunis Med</addtitle><date>2011-07</date><risdate>2011</risdate><volume>89</volume><issue>7</issue><spage>616</spage><epage>620</epage><pages>616-620</pages><issn>0041-4131</issn><abstract>Lung cancer is the most common malignancy diagnosed in patients with venous thrombo-embolism (VTE).
To investigate clinical, biological, radiological features and survival of lung cancer patients with VTE.
Retrospective case-control study investigating biologic, clinical course and survival of 25 patients lung cancers with VTE (Group M) and 50 lung cancers without VTE (group T).
The frequency of the VTE was 5.88% with 2.58% pulmonary embolism (PE). The mean age was 58 years ± 9.8 in group M and 57.9 years ± 9.6 in group T. No significant difference concerning medical or surgical history for both groups was found. The dyspnea and chest pain were at equal frequency (63.6%). Regarding the clinical probability of the PE, it was no significant differences between the two groups. A rate of D-dimer > 0.7μg/l was more frequent among group M (75% vs 20%; p = 0.054). The most common histological type was nonsmall cell lung cancer (88%). A stage IV was significantly more frequent in group M (86.4% vs. 52.3%; p = 0.007). The mean period of survival in Group M was 10.6 ± 1.2 month and 20.2 + 1.8 month in group T; p = 0.38.
The VTE associated to lung cancer is under diagnosed. Prospective studies are needed to establish more adapted scores.</abstract><cop>Tunisia</cop><pmid>21780036</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-4131 |
| ispartof | Tunisie Medicale, 2011-07, Vol.89 (7), p.616-620 |
| issn | 0041-4131 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_878823072 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Case-Control Studies Humans Lung Neoplasms - complications Male Middle Aged Retrospective Studies Venous Thromboembolism - diagnosis Venous Thromboembolism - etiology |
| title | Lung cancer with venous thrombo-embolism: clinical characteristics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T10%3A59%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lung%20cancer%20with%20venous%20thrombo-embolism:%20clinical%20characteristics&rft.jtitle=Tunisie%20Medicale&rft.au=Racil,%20Hajer&rft.date=2011-07&rft.volume=89&rft.issue=7&rft.spage=616&rft.epage=620&rft.pages=616-620&rft.issn=0041-4131&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E878823072%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=878823072&rft_id=info:pmid/21780036&rfr_iscdi=true |